Home Treatment for Acute Psychiatric Care
Primary Purpose
Mental Disorders
Status
Completed
Phase
Not Applicable
Locations
Switzerland
Study Type
Interventional
Intervention
Home treatment
Treatment As Usual
Sponsored by
About this trial
This is an interventional health services research trial for Mental Disorders
Eligibility Criteria
Inclusion Criteria:
- Need for acute psychiatric inpatient care
- Residence in the canton of Aargau
- Living within 30 minutes (by car) from the headquarters of the home treatment team
- Health insurance with tarifsuisse
Exclusion Criteria:
- Insufficient proficiency in German
- Main diagnosis F0 or F1 (ICD-10)
- Patients of the forencic departement
- Patients of the child and adolescent department
Sites / Locations
- Psychiatric Services Aargau AG
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Home treatment
Treatment as usual
Arm Description
Patients in need of acute psychiatric inpatient care are treated at their houses by mobile treatment teams instead of treatment at mental hospitals whenever home treatment is possible and appropriate.
Patients in need of acute psychiatric inpatient care are treated at a mental hospital.
Outcomes
Primary Outcome Measures
Number of inpatient days
Secondary Outcome Measures
Total days in treatment (inpatient + home treatment)
Direct treatment costs
Health of the Nation Outcome Scales (HoNOS)
Participants will be followed for the duration of hospital stay, an expected average of 4 weeks.
Brief Symptom Checklist (BSCL)
Participants will be followed for the duration of hospital stay, an expected average of 4 weeks.
Perceptions of Care-18
Participants will be assessed at discharge from hospital, after an expected average of 4 weeks.
Satisfaction of patients' relatives
Relatives' satisfaction will be assessed with an adapted version of the Perceptions of Care-18 questionnaire at discharge of the patients from hospital, after an expected average of 4 weeks. The proportion of satisfied relatives will be reported for both study arms.
Number of rehospitalizations per patient
Number of patients with adverse events
E.g. suicide or attempted suicide.
Full Information
NCT ID
NCT02322437
First Posted
December 11, 2014
Last Updated
June 3, 2018
Sponsor
Psychiatric Services Aargau AG
Collaborators
Hugo & Elsa Isler Foundation
1. Study Identification
Unique Protocol Identification Number
NCT02322437
Brief Title
Home Treatment for Acute Psychiatric Care
Official Title
Home Treatment for Acute Psychiatric Care in the Canton of Aargau (Switzerland): A Randomized Controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
June 2018
Overall Recruitment Status
Completed
Study Start Date
April 2015 (Actual)
Primary Completion Date
April 2018 (Actual)
Study Completion Date
April 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Psychiatric Services Aargau AG
Collaborators
Hugo & Elsa Isler Foundation
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
This study aims to evaluate whether psychiatric home treatment is an effective and efficient alternative to acute inpatient care in mental hospitals. A one-year prevalence cohort of psychiatric patients in need of hospitalization are randomly assigned to either treatment at inpatient wards (treatment as usual) or a new care model with the additional option of treating patients at their homes by mobile care teams. The primary focus is on checking whether optional home treatment leads to a reduction of inpatient days during a two-year follow-up period. In addition, the two service models will be compared regarding treatment cost and outcomes as well as satisfaction of patients and their relatives with psychiatric care.
Furthermore, a sub-cohort of randomly chosen patients from the prevalence-cohort will be examined by a highly trained clinical assessor to test and verify the diagnoses and the clinical ratings made by the staff members of the mental hospital under routine everyday conditions.
Detailed Description
This study aims to evaluate whether psychiatric home treatment is an effective and efficient alternative to acute inpatient care in mental hospitals. A one-year prevalence cohort of psychiatric patients in need of hospitalization are randomly assigned to either treatment at inpatient wards (treatment as usual) or a new care model with the additional option of treating patients at their homes by mobile care teams. The primary focus is on checking whether optional home treatment for crisis intervention leads to a reduction of inpatient days during a two-year follow-up period. In addition, the two service models will be compared regarding treatment cost and outcomes as well as satisfaction of patients and their relatives with psychiatric care.
Furthermore, a sub-cohort of randomly chosen patients from the prevalence-cohort will be examined by a highly trained clinical assessor to test and verify the diagnoses (SCID-I and SCID-II) and the clinical ratings (HoNOS) made by the staff members of the mental hospital under routine everyday conditions.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Mental Disorders
7. Study Design
Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
707 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Home treatment
Arm Type
Experimental
Arm Description
Patients in need of acute psychiatric inpatient care are treated at their houses by mobile treatment teams instead of treatment at mental hospitals whenever home treatment is possible and appropriate.
Arm Title
Treatment as usual
Arm Type
Active Comparator
Arm Description
Patients in need of acute psychiatric inpatient care are treated at a mental hospital.
Intervention Type
Other
Intervention Name(s)
Home treatment
Intervention Description
Patients are treated at home whenever possible and appropriate
Intervention Type
Other
Intervention Name(s)
Treatment As Usual
Intervention Description
Patients are treated at a mental hospital
Primary Outcome Measure Information:
Title
Number of inpatient days
Time Frame
2 years follow-up
Secondary Outcome Measure Information:
Title
Total days in treatment (inpatient + home treatment)
Time Frame
2 years follow-up
Title
Direct treatment costs
Time Frame
2 years follow-up
Title
Health of the Nation Outcome Scales (HoNOS)
Description
Participants will be followed for the duration of hospital stay, an expected average of 4 weeks.
Time Frame
Intake and discharge from treatment episode (expected average of 4 weeks)
Title
Brief Symptom Checklist (BSCL)
Description
Participants will be followed for the duration of hospital stay, an expected average of 4 weeks.
Time Frame
Intake and discharge from treatment episode (expected average of 4 weeks)
Title
Perceptions of Care-18
Description
Participants will be assessed at discharge from hospital, after an expected average of 4 weeks.
Time Frame
Discharge from treatment episode (expected average of 4 weeks)
Title
Satisfaction of patients' relatives
Description
Relatives' satisfaction will be assessed with an adapted version of the Perceptions of Care-18 questionnaire at discharge of the patients from hospital, after an expected average of 4 weeks. The proportion of satisfied relatives will be reported for both study arms.
Time Frame
Discharge from treatment episode (expected average of 4 weeks)
Title
Number of rehospitalizations per patient
Time Frame
2 years follow-up
Title
Number of patients with adverse events
Description
E.g. suicide or attempted suicide.
Time Frame
2 years follow-up
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
64 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Need for acute psychiatric inpatient care
Residence in the canton of Aargau
Living within 30 minutes (by car) from the headquarters of the home treatment team
Health insurance with tarifsuisse
Exclusion Criteria:
Insufficient proficiency in German
Main diagnosis F0 or F1 (ICD-10)
Patients of the forencic departement
Patients of the child and adolescent department
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Niklaus Stulz, PhD
Organizational Affiliation
Psychiatric Services Aargau AG
Official's Role
Principal Investigator
Facility Information:
Facility Name
Psychiatric Services Aargau AG
City
Brugg
State/Province
Aargau
ZIP/Postal Code
5201
Country
Switzerland
12. IPD Sharing Statement
Citations:
PubMed Identifier
30864532
Citation
Stulz N, Wyder L, Maeck L, Hilpert M, Lerzer H, Zander E, Kawohl W, Grosse Holtforth M, Schnyder U, Hepp U. Home treatment for acute mental healthcare: randomised controlled trial. Br J Psychiatry. 2020 Jun;216(6):323-330. doi: 10.1192/bjp.2019.31.
Results Reference
derived
Learn more about this trial
Home Treatment for Acute Psychiatric Care
We'll reach out to this number within 24 hrs